Points & Pearls • Free Excerpt
November 2026 • Volume 5 • Issue 11
Evidence-Based Evaluation and Treatment of Acute Rhinosinusitis in Adults
Infectious Disease CME • Pharmacology CME • Risk Management CME
Review key clinical takeaways from the accompanying Evidence-Based Urgent Care issue.
Points & Pearls Excerpt
- Most acute rhinosinusitis is viral; <2% of cases progress to acute bacterial rhinosinusitis (ABRS).
- Diagnosis of acute rhinosinusitis is primarily clinical and should focus on symptom duration, progression, and the presence of nasal obstruction, purulent drainage, and facial pain or pressure.
- Routine laboratory testing and imaging are not indicated for uncomplicated rhinosinusitis; advanced imaging should be reserved for suspected complications or high-risk presentations.
- Symptomatic care is appropriate for most patients, and systemic corticosteroids are not routinely recommended because of limited benefit and potential adverse effects.
Continue Reading the Companion Article
Already have access through your EB Medicine subscription?
Log in to continue to the companion article.






